Bibliographic Details
| Title: |
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma |
| Authors: |
Zugasti, Inés 1, Tormo-Ratera, Marta 1, Oliver-Caldés, Aina 1, 2, Soler-Perromat, Juan Carlos 1, González-Calle, Verónica 3, Moreno, David F. 1, Cabañas, Valentín 4, López-Muñoz, Nieves 5, Bartolomé-Solanas, Álvaro 1, Español-Rego, Marta 1, Reguera-Ortega, Juan Luis 6, Rosiñol, Laura 1, López-Corral, Lucía 3, Tovar, Natalia 1, Rodríguez-Lobato, Luis Gerardo 1, Alvarez Perez, Rosa Maria 6, Varea, Sara 1, Olesti, Eulàlia 1, Gomez-Grande, Adolfo 5, Frutos, Laura 4, Tamayo, Pilar 3, Juan, Manel 1, Moraleda, José M. 4, Urbano-Ispizua, Álvaro 1, González-Navarro, E. Azucena 1, Martínez-López, Joaquín 5, Mateos, Maria-Victoria 3, Tomás, Xavier 1, Setoain, Xavier 1, 7, Fernández de Larrea, Carlos 1, ∗ |
| Source: |
In Blood Advances 11 February 2025 9(3):571-582 |
| Database: |
ScienceDirect |
